- Home
- SKT vs AAPG Comparison
SKT vs AAPG Comparison
Compare SKT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKT
- AAPG
- Stock Information
- Founded
- SKT 1981
- AAPG 2009
- Country
- SKT United States
- AAPG China
- Employees
- SKT N/A
- AAPG N/A
- Industry
- SKT Real Estate Investment Trusts
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- SKT Real Estate
- AAPG Health Care
- Exchange
- SKT Nasdaq
- AAPG Nasdaq
- Market Cap
- SKT 3.3B
- AAPG 3.6B
- IPO Year
- SKT 1993
- AAPG 2025
- Fundamental
- Price
- SKT $31.52
- AAPG $39.76
- Analyst Decision
- SKT Buy
- AAPG Buy
- Analyst Count
- SKT 9
- AAPG 1
- Target Price
- SKT $36.44
- AAPG N/A
- AVG Volume (30 Days)
- SKT 987.9K
- AAPG 9.6K
- Earning Date
- SKT 08-04-2025
- AAPG 08-06-2025
- Dividend Yield
- SKT 3.71%
- AAPG N/A
- EPS Growth
- SKT N/A
- AAPG N/A
- EPS
- SKT 0.85
- AAPG N/A
- Revenue
- SKT $549,227,000.00
- AAPG $134,352,180.00
- Revenue This Year
- SKT $0.45
- AAPG N/A
- Revenue Next Year
- SKT $4.18
- AAPG $389.09
- P/E Ratio
- SKT $37.12
- AAPG N/A
- Revenue Growth
- SKT 12.63
- AAPG 341.77
- 52 Week Low
- SKT $26.62
- AAPG $16.50
- 52 Week High
- SKT $37.57
- AAPG $43.58
- Technical
- Relative Strength Index (RSI)
- SKT 53.43
- AAPG N/A
- Support Level
- SKT $31.41
- AAPG N/A
- Resistance Level
- SKT $31.92
- AAPG N/A
- Average True Range (ATR)
- SKT 0.60
- AAPG 0.00
- MACD
- SKT -0.04
- AAPG 0.00
- Stochastic Oscillator
- SKT 28.28
- AAPG 0.00
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.